The effect of comprehensive lifestyle intervention or metformin on obesity in young women

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 4, 2011, Pages 261-268

  Lim, S S ^a,b   Norman, R J ^a   Clifton, P M ^b   Noakes, M ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

Author keywords

Clinical trials; Drug treatment; Lifestyle modifications; Weight loss; Women

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR THERAPY; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; LIFESTYLE; OBESITY; PATIENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BEHAVIOR THERAPY; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INTENTION TO TREAT ANALYSIS; LIFE STYLE; METFORMIN; OBESITY; OVERWEIGHT; PATIENT COMPLIANCE; PATIENT DROPOUTS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79952699676     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.10.006     Document Type: Article

References (25)

1. McTigue K.M., Garrett J.M., Popkin B.M. The natural history of the development of obesity in a cohort of young U.S. adults between 1981 and 1998. Ann Intern Med 2002, 136:857-864.
2. Kuczmarski R.J. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 1992, 55:495S-502S.
3. Colditz G.A., Coakley E. Weight, weight gain, activity, and major illnesses: the Nurses' Health Study. Int J Sports Med 1997, 3(18 Suppl):S70-S162.
4. Fairfield K.M., Willett W.C., Rosner B.A., Manson J.E., Speizer F.E., Hankinson S.E. Obesity, weight gain, and ovarian cancer. Obstet Gynecol 2002, 100:288-296.
5. Franz M.J., VanWormer J.J., Crain A.L., Boucher J.L., Histon T., Caplan W., et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007, 107:1755-1767.
6. Honas J.J., Early J.L., Frederickson D.D., O'Brien M.S. Predictors of attrition in a large clinic-based weight-loss program. Obes Res 2003, 11:888-894.
7. Salpeter S.R., Buckley N.S., Kahn J.A., Salpeter E.E. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med 2008, 121:149-157.
8. Lord J.M., Flight I.H., Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Bmj 2003, 327:951-953.
9. Lachin J.M., Christophi C.A., Edelstein S.L., Ehrmann D.A., Hamman R.F., Kahn S.E., et al. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 2007, 56:1153-1159.
10. Crandall J., Schade D., Ma Y., Fujimoto W.Y., Barrett-Connor E., Fowler S., et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006, 61:1075-1081.
11. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
12. Australian Government DoHaA Australian Guide to healthy eating http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pubhlth-strateg-food-guide-whatis.htm.
13. Australian Government DoHaA National physical activity guidelines for adults http://www.health.gov.au/internet/wcms/publishing.nsf/Content/phd-physical-activity-adults-pdf-cnt.htm.
14. Hill J.O., Wyatt H.R. Role of physical activity in preventing and treating obesity. J Appl Physiol 2005, 99:765-770.
15. Moran L.J., Noakes M., Clifton P.M., Tomlinson L., Galletly C., Norman R.J. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:812-819.
16. National Institute of Health NH, Lung and Blood Institute. 2002 Third report of the National cholesterol education program (NCEP). Expert Panel Detection Eval Treat High Blood Cholesterol Adults (Adult Treat Panel NIH Publ No. 05-5215).
17. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
18. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Huber-Buchholz M.M., Carey D.G., Norman R.J. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999, 84:1470-1474.
21. Mallinckrodt C.H., Clark W.S., David S.R. Accounting for dropout bias using mixed-effects models. J Biopharm Stat 2001, 11:9-21.
22. Stevens J., Truesdale K.P., McClain J.E., Cai J. The definition of weight maintenance. Int J Obes (Lond) 2006, 30:391-399.
23. Wu R.R., Zhao J.P., Jin H., Shao P., Fang M.S., Guo X.F., et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008, 299:185-193.
24. Welch N., McNaughton S.A., Hunter W., Hume C., Crawford D. Is the perception of time pressure a barrier to healthy eating and physical activity among women?. Public Health Nutr 2008, 1-8.
25. Dattilo A.M., Kris-Etherton P.M. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992, 56:320-328.